CSI Market
Sign In | Register

Niagen Bioscience Inc (NAGE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NAGE Annual Balance Sheets →
This page allows investors to track Niagen Bioscience Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & Short-term Investments0.00
Accounts receivable8.58
Inventories20.64
Other Current Assets66.74
Total loans net1.83
Total Current Assets97.79
Intangible Assets5.31
Prepaid Expense and Other Assets, Total0.00
Other Assets, Noncurrent3.49
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization1.30
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents66.55
Operating Lease Right Of Use Asset2.02
Total Assets106.59
Liabilities
Accounts Payable, Current AC9.44
Accrued Liabilities, Current AC3.84
Other Liabilities, Current1.25
Deferred Compensation Liability, Current LI0.52
Total Current Liabilities15.05
Total Long-term Debt0.00
Deferred Compensation Liability, Classified, Noncurrent LI5.17
Other liabilities, Noncurrent3.85
Operating Lease Liability Current1.03
Operating Lease Liability Noncurrent1.54
Total Liabilities24.06
Stockholders' Equity
Translation Adjustment Functional To Reporting Currency Net Of Tax0.00
Common Stock Value0.08
Additional Paid In Capital Common Stock239.70
Retained Earnings / Accumulated Deficit-157.25
Other Equity0.00
Common Stockholder's Equity82.53
Total Stockholder's Equity82.53
Liabilities & Stockholder's Equity106.59
4 historic quarters locked

Sign in to unlock the full Niagen Bioscience Inc balance sheet history.

Sign In Create Free Account

About Niagen Bioscience Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001386570-26-000043

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.